Skip NavigationSkip to Content
Return Return to Search Results

A high-throughput screen for identification of molecular mimics of Smac/DIABLO utilizing a fluorescence polarization assay

  1. Author:
    Glover, C. J.
    Hite, K.
    DeLosh, R.
    Scudiero, D. A.
    Fivash, M. J.
    Smith, L. R.
    Fisher, R. J.
    Wu, J. W.
    Shi, Y. G.
    Kipp, R. A.
    McLendon, G. L.
    Sausville, E. A.
    Shoemaker, R. H.

  2. Author Address

    NCI, Dev Therapeut Program, Frederick, MD 21702 USA NCI, Dev Therapeut Program, Frederick, MD 21702 USA NCI, SAIC, Frederick, MD 21702 USA Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA Princeton Univ, Dept Chem, Princeton, NJ 08544 USA NCI, Dev Therapeut Program, Bethesda, MD 20892 USA Glover CJ NCI, Dev Therapeut Program, Frederick, MD 21702 USA
    1. Year: 2003
  2. Journal: Analytical Biochemistry
    1. 320
    2. 2
    3. Pages: 157-169
  4. Type of Article: Article
  1. Abstract:

    Resistance to apoptosis is afforded by inhibitor of apoptosis proteins (IAPs) which bind to and inhibit the caspases responsible for cleavage of substrates leading to apoptotic cell death. Smac (or DIABLO), a proapoptotic protein released from the mitochondrial intermembrane space into the cytosol, promotes apoptosis by binding to IAPs, thus reversing their inhibitory effects on caspases. We have developed a high- throughput fluorescence polarization assay utilizing a fluorescein-labeled peptide similar to the "IAP binding" domain of Smac N terminus complexed with the BIR3 domain of X-linked IAP (XIAP) to identify small-molecule mimics of the action of Smac. The IC(50)s of peptides and a tetrapeptidomimetic homologous to the N terminus of Smac demonstrated the specificity and utility of this assay. We have screened the National Cancer Institute "Training Set" of 230 compounds, with well-defined biological actions, and the "Diversity Set" of 2000 chemically diverse structures for compounds which significantly reduced fluorescence polarization. Highly fluorescing or fluorescence-quenching compounds (false positives) were distinguished from those which interfered with Smac peptide binding to the XIAP-BIR3 in a dose-dependent manner (true positives). This robust assay offers potential for high-throughput screening discovery of novel compounds simulating the action of Smac/DIABLO. (C) 2003 Elsevier Science (USA). All rights reserved.

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel